| 204.72 Delayed Data As of Oct 18 |  -0.12 / -0.06%Today’s Change | 177.70 Today|||52-Week Range 297.93 | +7.79% Year-to-Date |
| Reata Pharmaceuticals Repositions Itself for Success Oct 16 / MotleyFool.com - Paid Partner Content |
| Previous close | 204.84 |
| Today’s open | 203.66 |
| Day’s range | 202.85 - 205.87 |
| Volume | 465,517 |
| Average volume (3 months) | 527,704 |
| Market cap | $10.6B |
| Earnings growth (last year) | +96.65% |
| Earnings growth (this year) | +16.61% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +33.09% |
| P/E ratio | 9.5 |
| Price/Sales | 3.81 |
| Price/Book | 2.11 |
| Today’s change | Today’s % change | |
|---|---|---|
| ALLYAlly Financial Inc | -0.24 | -0.79% |
| CBSHCommerce Bancshares ... | +0.48 | +0.77% |
| SBNYSignature Bank | +1.78 | +1.47% |
| EWBCEast West Bancorp In... | -0.07 | -0.17% |
| Next reporting date | October 25, 2019 |
| EPS forecast (this quarter) | $5.00 |
| Annual revenue (last year) | $2.7B |
| Annual profit (last year) | $973.8M |
| Net profit margin | 36.37% |
Sector Finance |
Industry Regional Banks |
No executives to display |
Corporate headquarters Santa Clara, California |
